TY - JOUR AU - Hirayasu, Yoshio AU - Sato, Shin-Ichi AU - Takahashi, Hideaki AU - Iida, Sayaka AU - Shuto, Norifumi AU - Yoshida, Seitaro AU - Funatogawa, Takashi AU - Yamada, Takahito AU - Higuchi, Teruhiko PY - 2016 DA - 2016/03/15 TI - A double-blind randomized study assessing safety and efficacy following one-year adjunctive treatment with bitopertin, a glycine reuptake inhibitor, in Japanese patients with schizophrenia JO - BMC Psychiatry SP - 66 VL - 16 IS - 1 AB - Bitopertin, a glycine reuptake inhibitor, was investigated as a novel treatment for schizophrenia. We report all the results of a double-blind randomized study assessing safety and efficacy following 52-week adjunctive treatment with bitopertin in Japanese patients with schizophrenia. SN - 1471-244X UR - https://doi.org/10.1186/s12888-016-0778-9 DO - 10.1186/s12888-016-0778-9 ID - Hirayasu2016 ER -